BackPURE Bioscience Overview

PURE Bioscience Long Term Debt

Track PURE Bioscience's long-term debt ($3.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$3.74M
↓ 23.60% YoYΔ $-1.16M vs prior year quarter

Peer average

Loading

PURE Bioscience Long Term Debt History

Loading

PURE Bioscience vs. peers: Long Term Debt Comparison

Loading

PURE Bioscience Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PURE Bioscience (PURE) FAQ

PURE Bioscience posts a long-term debt of $3.7M as of April 2026. That compares with $4.9M in the prior-year period — down 23.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, PURE Bioscience's long-term debt was $4.9M. The latest reading is $3.7M — a 23.6% year-over-year decrease (period ending April 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of PURE Bioscience's financial statement story. At $3.7M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PURE's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; PURE Bioscience's other metric pages and overview cover the third.